Steinbeißer Project Management
Some news ...
Giving patients a voice in drug development - PREFER is a five year project funded by the Innovative Medicines Initiative (IMI), to evaluate different preference elicitation methods and test them in a clinical setting.
16 pharmaceutical companies and 16 public partners form the project consortium with a total budget of 12 million €.
For more info: www.imi-prefer.eu